Skip to main content

Dynacure S.A. (DYCU)

Dynacure was planning to go public, but the IPO has been withdrawn.
Stock Price: $15.00 - $17.00
Current IPO price range
Chart not available yet
Market Cap314.81M
Revenue (ttm)n/a
Net Income (ttm)-18.57M
Shares Out19.68M
EPS (ttm)-0.94
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Openn/a
Previous Closen/a
Day's Rangen/a
52-Week Rangen/a
Betan/a
Analystsn/a
Price Targetn/a
Est. Earnings Daten/a

About DYCU

Dynacure S.A. is a clinical-stage company focused on developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. We are initially focused on developing treatments for neuromuscular diseases, beginning with myotubular and centronuclear myopathies, or CNM, a group of devastating rare genetic disorders characterized by severe muscle weakness, or myopathy, with shortened life expectancy and significant morbidity. Our lead product candidate, DYN101, is an antisense ol...

IndustryPharmaceutical Preparations
IPO DateWithdrawn
CEOStéphane van Rooijen, M.D, M.B.A.
Employees22
Stock ExchangeNASDAQ
Ticker SymbolDYCU
Full Company Profile

Financial Performance

Financial numbers in millions EURFinancial Statements

News

Dynacure S.A. IPO Registration Document (S-1)

Dynacure S.A. has filed to go public with an IPO on the NASDAQ.

2 months ago - SEC